Alnylam Pharmaceuticals Inc. (ALNY) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alnylam Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Alnylam Pharmaceuticals Inc. (ALNY) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $30.3B. It trades at $232.40, up 2.47% today, at 40.1 times earnings. Its overall quality score is 70 out of 100, ranked against the whole US market. 23 analysts' average target of $363.39 implies +56.4% from today's price. Kronos AI's 30-day forecast is +7.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $363.39 |
| Low – high | $253.00 – $489.00 |
| Analysts | 23 |
| Upside to average | +56.4% |
Kronos AI 30-day forecast
| Expected close | $244.70 (+7.9%) |
| Likely range | +5.8% … +10.9% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 77 |
| Solvency | 42 |
| Growth | 90 |
| Overall | 70 |
| P/E | 40.1 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator